- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
The New York Post reported yesterday on four U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) audits of state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism programs. Two of the programs whose audits were reported are contiguous to Michigan: Indiana and Wisconsin. No indication if or when the MDHHS ABA program will be audited by the Feds. Michigan-based Centria Healthcare LLC has distributed over half a billion in Medicaid reimbursements:
https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/srs-a-25-029/
HHS finds up to $600m ‘improper’ payments for autism services, errors on every bill checked in four states
By Chadwick Moore - March 3, 2026It’s not just Minnesota where people have bilked Medicaid for millions.
Federal auditors found $198 million “improper payments” for Medicaid-funded autism services in four states, and another $410 million may have been incorrectly billed.
The Department of Health and Human Services (HHS) put Medicaid spending for autism care in Indiana, Wisconsin, Maine and Colorado under the microscope, examining 100 monthly bills in each state over a year.
They found potential payment errors in every single one.
According to the audits, Indiana made at least $56 million in improper payouts, Wisconsin $18.5 million, Maine $45.6 million and Colorado a whopping $77.8 million.
Between 2019 and 2025, Medicaid spending on Applied Behavior Analysis (ABA) therapy—the primary treatment protocol for children with autism—has skyrocketed 298% nationwide, according to a report from healthcare analytics company Trilliant Health.
Tatsiana – stock.adobe.comIn 2014, new federal rules required Medicaid to cover autism care. Since then, Autism spectrum disorder (ASD) prevalence in the United States has nearly doubled, from about one in 64 children in 2014 to one in 36 in 2020, with much of the rise attributed to changing diagnostic criteria, increased screening, and greater public awareness.
Payments should not have been made due to reasons like caregivers failed to properly document therapy sessions, lacked the appropriate credentials to provide treatment or patients had not been properly diagnosed with autism.
In addition, in each case the audits flagged separate “potentially improper payments” in each state, which was a much higher number: up to $77 million in Indiana, $22 million in Maine, $94 million in Wisconsin and $207 million in Colorado.
These payments were flagged as carers billing for potential non-therapy time and during recreational activities and not keeping proper notes of the care.
“There’s a big myth that needs to be busted, is the idea that states and the federal government equally share the goal of reducing improper spending,” Chris Medrano, an analyst at the free-market health care research group Paragon Health, told The Post.
He also claimed “a lot” of states use “funding gimmicks” to redirect boatloads of Medicaid money into their general funds, suggesting they may be incentivized to keep the gravy train flowing and turn a blind eye to overbilling.
Although no companies have been prosecuted for fraud related to the HHS audits at this time, the federal government has requested the return of millions of dollars in improper payments from each of the states.
More children are being diagnosed with autism in the US, largely due to increased screening, greater public awareness and a widening of the definition on what counts as autism. Key revisions in 2013 merged previously separate diagnoses into a single Autism Spectrum Disorder (ASD) umbrella.
Feds found “improper or potentially improper” payments in 100 percent of Medicaid-funded autism services sampled across four states in recently published findings—totaling up to $198 million in potentially fraudulent payouts.
Diagnosis rates have gone from 1 in 150 children in 2000 to 1 in 31 children in 2022, according to the CDC.
Some autism researchers, however, have criticized the supposed “epidemic” in autism by suggesting that the new broad criteria has contributed to overdiagnosis.
In 2014, new federal rules required Medicaid to cover autism care. Since then, Medicaid spending on Applied Behavior Analysis (ABA) therapy — the primary treatment protocol for children with autism — has skyrocketed 298% nationwide from seven million hours of therapy administered to 25 million a year in 2024, according to a report from healthcare analytics company Trilliant Health.
Centria Healthcare was the largest Medicaid funded autism care center in the nation, with operations in 12 states as rates of autism diagnoses have exploded since 2014.
As our graph charts, In Indiana, ABA spending rose from $21 million in 2017 to $611 million in 2023 and is projected to reach $825 million by 2029.
North Carolina ABA spending grew from $122 million in 2022 to $329 million by 2024. It is projected to reach an eye-popping $639 million this year.
ABA spending in Nebraska surged from $4.6 million in 2020 to over $83 million in 2024. One provider, Above and Beyond ABA, billed for $29 million alone, according to a state report (it is not suggested they were part of the overbilling).
Colorado ABA payments were $60 million in 2019 and, and $164 million by 2023.
Brown University researcher Daniel Arnold told The Post: “The increases you’re seeing in some states are astronomical […] When private equity comes in usually the price increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
However, none has been more eyepopping than Minnesota which received just over $1 million in Medicaid reimbursements for autism care in 2017, but by 2024 that number had skyrocketed to $343 million, according to the Minnesota Department of Human Resources.
As part of numerous federal prosecutions centered around the Somali community in Minneapolis, in September Asha Farhan Hassan and Abdinajib Hassan Yussuf both pleaded guilty to an autism fraud scheme in Minnesota. Hassan owned Smart Therapy Center and was found to have hired unqualified staff, paid kickbacks of $300–$1,500 per month to parents to recruit children — some not diagnosed with autism — billed for services not provided or inflated hours, and submitted false documentation between 2019 and 2024, according to the Department of Justice.
With all the money sloshing around, private equity has taken note of the seemingly recession-proof profitability potential of Medicaid-funded autism centers.
President Trump announced during last week’s State of the Union address that VP Vance would be heading up the administration’s “war on fraud.”
Quality Learning Center in Minnesota became an emblem of the Minnesota fraud, after allegations it was collecting funds but providing no services. It has since been closed.
In the last decade, private equity firms have acquired over 500 autism centers in the US, according to a January 2026 Brown University study.
Among them, Michigan-based Centria Healthcare LLC, a business which has distributed over half a billion in Medicaid reimbursements. It was acquired by private equity firm Thomas H. Lee Partners in 2019.
Indiana-based Hopebridge LLC, backed by PE firm Arsenal Capital Partners, has also taken in at least $140 million, according to the data.
“The increases you’re seeing in some states are astronomical,” Daniel Arnold, a health policy researcher at Brown University, told The Post.
“When private equity comes in, usually the price [of care] increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
Medicaid fraud has been a hot topic since it was revealed last fall that Somali scammers in Minnesota had bilked the state out of an estimated $9 billion in similar schemes.
“It’s not obvious to me that, say, 40 hours a week of ABA is better than 20. It gets to a point where you are crowding out other services kids are doing —like speech therapy, occupational therapy or play activities,” he added.
For those who are proven to have inflated bills, there are consequences.
Two executives at South Carolina Early Autism Project, Angela Breitweiser Keith and Ann Davis Eldridge, were sentenced to a year in prison in 2019 and paid $8.8 million in a settlement for using autism services to defraud Medicaid.
The Department of Justice said the execs had instructed employees to bill for time waiting in driveways and sitting in restaurants; pressured employees to submit exaggerated session timesheets; forged patient signatures and incentivized fraud by establishing high billing goals with rewards like gift cards and company-paid vacations for those who met quotas.
During last week’s State of the Union address, President Trump announced he was appointing Vice President JD Vance to lead a “war on fraud” task force.
“The gold standard solution would be to have some sort of set funding because right now Medicaid is an open-ended reimbursement,” said Medrano. “Have the state internalize the cost of Medicaid so they’re incentivized to save money.”
Sylvia Xu of The Epoch Times teases more conclusions out of the HHS-OIG audit of Colorado's state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism program:
100 Percent of Audited Medicaid Claims for Autism Care in Colorado Were Improper or Flawed: Report
Colorado Medicaid spending on Applied Behavior Analysis rose 280 percent in five years and suffers from a lack of oversight, according to the Inspector General.
By Sylvia Xu - March 5, 2026Colorado’s Medicaid program made an estimated $77.8 million in improper payments and another $207.4 million in potentially improper payments for autism therapy, according to a February report from the Inspector General for the Department of Health and Human Services.
Auditors investigated $289.5 million in Medicaid payments from 2022 to 2023 that paid for more than 1 million claims for Applied Behavior Analysis—a therapy used to treat autism and developmental disabilities.
Each of the 100 claims reviewed contained at least one improper or potentially improper payment, suggesting a 100 percent failure rate.
Improper payments are not necessarily fraudulent. Payments are considered improper when the claim does not meet federal or state requirements. Payments are potentially improper when the submitted claim is so poor or unreliable that auditors cannot verify that the services were provided correctly.
Claim Errors
In 93 of 100 claims examined, the billing providers either did not provide notes verifying that the therapy took place, didn’t provide the required signatures, or billed for more time than the notes indicated.
In 18 cases, the therapy that was supposed to be performed by a specialist—such as a Board Certified Behavior Analyst—was performed by staff without those qualifications.In seven cases, the children receiving therapy lacked a current doctor’s diagnosis or referral on file.
In 88 cases, facilities billed for recreational activities that are not considered medical therapy, such as academic tutoring, day care, or custodial care. In one case, a facility billed for children swimming and playing on water slides.
In 76 cases, facilities billed for a full eight-hour day without subtracting time for naps, meals, or breaks.
Oversight and Safety Concerns
The report concludes that Colorado made these improper payments because it did not provide effective oversight. The state did not regularly review Medicaid payments to catch errors and failed to give clear guidance to therapy centers on how to bill or what counts as therapy.
Additionally, the state didn’t properly check if its prior authorization contractors were following the rules when approving therapy for children.While the audit focused on money, it also uncovered problems that could affect the safety and quality of care.
Some staff members had criminal convictions for weapons offenses, assault, or driving under the influence. In one case, three staff members at a facility providing care to an 11-year-old child with autism had criminal histories.
A non-credentialed technician had a felony weapons offense conviction three months prior to treating children. A registered behavior technician had been convicted of misdemeanor assault and physical harassment, such as a strike, shove, or kick. Another behavior technician had an aggravated misdemeanor weapons conviction.
The state did not require background checks for these workers.
Previous Audits
The report comes as part of a series of seven Inspector General audits examining state Medicaid payments for autism therapy. Four are are complete and three remain in progress.
In previous audits, the agency estimated more than $120 million in improper payments and nearly $200 million in potential improper payments for Indiana, Wisconsin, and Maine.
The potential fraud, waste, and abuse in Medicaid autism therapy payments in Colorado was the highest among these audits.
The Office of Inspector General recommended that Colorado refund $42.6 million—the federal portion of the improper payments—to the federal government.
Also, the agency suggested that the state begin regular reviews of autism facilities to ensure they follow the rules and provide better training and guidance to facilities on documenting and billing for therapy.
The state of Colorado agreed to improve its guidance and conduct more regular reviews in the future, according to a statement. But it disagreed with the recommendation to refund the money, arguing that the audit derived its findings from a limited sample and didn’t have enough detail on the errors.
Further, Colorado argued that its Medicaid program does not require certification of behavior technicians before making payments, so the refund calculation based on this statute should be rescinded.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















